FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST - Fig 7
- Edouard Depardon (5518613)
- Salim Kanoun (814758)
- Olivier Humbert (814764)
- Aurélie Bertaut (3749977)
- Jean-Marc Riedinger (54443)
- Ilan Tal (814759)
- Jean-Marc Vrigneaud (814762)
- Maud Lasserre (5518610)
- Michel Toubeau (5518616)
- Alina Berriolo-Riedinger (814760)
- Inna Dygai-Cochet (5518607)
- Pierre Fumoleau (805608)
- François Brunotte (87012)
- Alexandre Cochet (87005)
Publication date
July 2018
DOIAbstract
<p>Overall survival stratified by metabolic response (complete or non-complete) according to EORTC criteria (A) and PERCIST (B) in patients with luminal breast cancer (phenotype with the best prognosis during at the time of the study).</p
Add to ORKG